Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis

Indian Journal of Medical Research

Volumn 133, Issue 3, 2011, Pages 308-311

  Sharma, Surendra K ^a   Kaushik, Gaurav ^a   Jha, Brajesh ^a   George, Ninoo ^a   Arora, S K ^c   Gupta, Deepak ^a   Singh, Urvashi ^b   Hanif, Mahmud ^d   Vashisht, R P ^d  

^a Department of Medicine ^*  (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c Sanjay Gandhi Memorial Hospital   (India)

^d New Delhi Tuberculosis Centre   (India)

Author keywords

Drug resistance; India; Multidrug resistant tuberculosis (MDR TB); New case pulmonary tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SPUTUM CULTURE; ADOLESCENT; MICROBIOLOGY; SPUTUM;

ADOLESCENT; ADULT; FEMALE; HUMANS; INDIA; MALE; PREVALENCE; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 79952937022     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. The WHO / IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World. Report No.4. Geneva, Switzerland: WHO; WHO/HTM/TB/2008.394.
2. Sharma SK, Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 2006; 130: 261-72.
3. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887-93.
4. Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rüsch-Gerdes S, et al. A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist 2005; 11: 62-7.
5. Paramasivan CN, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004; 120: 377-86.
6. Snider DE Jr, Kelly GD, Cauthen GM, Thompson NJ, Kilburn JO. Infection and disease among contacts of tuberculosis cases with drug resistant and drug susceptible bacilli. Am Rev Respir Dis 1985; 132: 125-32.
7. Revised National Tuberculosis Control Programme (RNTCP). RNTCP at a glance. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi, Government of India. Available from: http://uttarkashi.nic.in/Dept/Health/RNTCP/ RNTCP.pdf, accessed on January 26, 2010.
8. Chandrasekaran S, Chauhan MM, Rajalakshmi R, Chaudhuri K, Mahadev B. Initial drug resistance to anti-tuberculosis drugs in patients attending an urban district tuberculosis centre. Indian J Tuberc 1990; 37: 215-6.
9. Narang P, Nayar S, Mendiratta DK, Tyagi NK, Jajoo U. Smear and culture positive cases of pulmonary tuberculosis found among symptomatics surveyed in Wardha district. Indian J Tuberc 1992; 39: 159-63.
10. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM, Prabhakar R. Bacteriological investigations for short course chemotherapy under the tuberculosis programme in two districts of India. Tuber Lung Dis 1993; 74: 23-7.
11. Chandrasekaran S, Jagota P, Chaudhuri K. Initial drug resistance to antituberculosis drugs in urban and rural district tuberculosis programme. Indian J Tuberc 1992; 39: 171-5.
12. Gupta PR, Singhal B, Sharma TN, Gupta RB. Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Indian J Med Res 1993; 97: 102-3.
13. Jain NK, Chopra KK, Prasad G. Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992; 39: 12-4.
14. Jena J, Panda BN, Nema SK, Ohri VC, Pahwa RS. Drug resistance pattern of Mycobacterium tuberculosis in a chest diseases hospital of armed forces. Lung India 1995; 13: 56-9.
15. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V, Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000; 47: 27-33.
16. Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR. Surveillance of drug resistance in tuberculosis in two districts of south India. Int J Tuberc Lung Dis 2002; 6: 479-84.
17. Anuradha B, Aparna S, Hari Sai Priya V, Vijaya Lakshmi V, Akbar Y, Suman Latha G, et al. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003. Int J Tuberc Lung Dis 2006; 10: 58-62.
18. Joseph MR, Shoby CT, Amma GR, Chauhan LS, Paramasivan CN. Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. Int J Tuberc Lung Dis 2007; 11: 443-9.
19. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, et al. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009; 13: 1154-60.
20. Jain A, Mondal R, Prasad R, Singh K, Ahuja RC. Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian J Med Res 2008; 128: 300-6.
21. D'souza DT, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G, et al. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 2009; 211: 1-9.